ABSTRACT
Two cases of bursitis complicated by rice bodies (C.O., corpora oryzoidea) are described. One case occurred after local elbow trauma, in the other case tuberculous bursitis was found. C.O. is a rare manifestation of fibrinous inflammation, seen not only in TB but also, perhaps more frequently, in rheumatoid conditions. Removal of the bursa and C.O. followed by microscopic investigation is recommended.
Subject(s)
Bursitis/complications , Joint Loose Bodies/complications , Tuberculosis, Osteoarticular/complications , Adult , Bursitis/diagnosis , Bursitis/pathology , Diagnosis, Differential , Elbow Joint/pathology , Humans , Joint Loose Bodies/diagnosis , Joint Loose Bodies/pathology , Male , Shoulder Joint/pathology , Terminology as Topic , Tuberculosis, Osteoarticular/diagnosis , Tuberculosis, Osteoarticular/pathologyABSTRACT
A case of glucagonoma of the pancreas, without necrolytic migratory erythema, but accompanied by lethal pulmonary embolism in a 36 year old man is presented. The pathology, epidemiology and treatment of the glucagonoma syndrome is briefly described.
Subject(s)
Glucagonoma/pathology , Pancreatic Neoplasms/pathology , Pulmonary Embolism/diagnosis , Adult , Diagnosis, Differential , Glucagonoma/complications , Glucagonoma/therapy , Humans , Male , Pancreatic Neoplasms/complications , Pancreatic Neoplasms/therapy , Pulmonary Embolism/etiology , RecurrenceABSTRACT
The presence of more than four primary malignant tumours in a single patient was investigated in the Danish Cancer Registry. Four patients with five primary malignancies and one patient with six primary malignancies were found. All of the tumours were verified histologically and there was convincing evidence that none of the tumours were secondaries. In some of the cases, clustering of tobacco-associated cancers was observed. The anticipated number of cases with more than four primary malignancies was computed and it was found that less than one case would be anticipated. It is concluded that some cancer patients have an increased risk of developing a new primary malignancy.